Registration & Itinerary Collection
Welcome Remarks from World BI
Amraj Dhillon
Key Account Manager
World BI
Chairperson Welcome Address
Isabelle Naëije, PMP
Assoc. Global Trial Director
Novartis
Presentation 1: Maintenance of ethical balance between research strategy and clinical trial efficacy
Tali Schaffer
Exe. Director (develop treatments to neometals)
ELGAN Pharma
Presentation 2: Concept of smart trials: New technique to optimize clinical studies
Interactive Discussion: Redesigning the Clinical Research Environment
Panelists:
Isabelle Naëije, PMP
Assoc. Global Trial Director
Novartis
Dr. Andriy Krendyukov
VP Medical Affairs
Coffee Break & Networking Session
Presentation 3: Patient represent the "last mile of knowledge" to improve clinical outcomes
- Sensitivity and knowledge when it comes to patients
- The 'Modern Role' of patient in the Healthcare System
- Rethink Patient Journey in a 360° holistic view
Andrea Forgione, HSBA
Global Lead, Patient Engagement & Advocacy - Owner of Global Trasparency Process
MENARINI Group
Presentation 4: Guiding Clinical Research by Involving Patients from A to Z, to improve quality and success
Francois Houyez
Treatment Information and Access Director / Health Policy Advisor
European Organisation for Rare Diseases (Eurordis)
Presentation 5: Improving patient engagement by reducing barriers in clinical trials
Presentation 6: Regulatory Guidelines for Patient Data Transparency in Clinical Trials
Dr Solange Corriol-Rohou, MD
Senior Director Regulatory Affairs & Policy, Europe
AstraZeneca
Fire Side Chat: Clinical Operations 3.0….What will Clinical Operations look like in the year 2050
Moderator
Bernhard Glombitza
Head Clinical Operations EMEA & APAC, VP
Bayer Pharmaceuticals
Panelist:-
Jessica Cordes
Senior Clinical Operations Expert
Presentation 7: Clinical trials with cell and gene therapy along with key operational elements and best practises
Jessica Cordes
Senior Clinical Operations Expert
Presentation 8: GCP (Good Clinical Practices) Quality and Risks in Decentralized Clinical Trials
Konstantinos Tsekmes
Associate Director Clinical Operations
MSD
Coffee Break & Networking Session
Interactive Discussion: Rare diseases and decentralized clinical trials
Moderator:-
Dr Solange Corriol-Rohou, MD
Senior Director Regulatory Affairs & Policy, Europe
AstraZeneca
Panelist:-
Dr. Andriy Krendyukov
VP Medical Affairs
Presentation 9: The era of Precision Medicine for clinical oncology trials: Current Context, Best Operational Practices
Dr. Harsha Doddihal
Vice President Clinical Development
Glenmark Pharmaceuticals
Interactive Discussion: Decentralized Clinical Trials or AI in clinical trials?
Isabela Niculae, MPH
Head Global Clinical Sciences & Operations Innovation
UCB
Chair Closing Remarks
Isabelle Naëije, PMP
Assoc. Global Trial Director
Novartis